11 new COVID cases; walk-in vaccine clinic Friday in Carson City


  • Discuss Comment, Blog about
  • Print Friendly and PDF
 Carson City Health and Human Services on Wednesday reported 11 new cases and 27 additional recoveries of COVID-19 in the Quad-County Region.
This brings the total number of cases to 12,650, with 12,117 recoveries and 226 deaths; 307 cases remain active.

Total Cases 

Active Cases

Recoveries

Deaths

*Population

Carson City

6,486

126

6,237

123

56,546

Douglas County

2,861

77

2,749

35

49,695

Lyon County

3,193

96

3,032

65

57,987

Storey County

110

8

99

3

4,465

Quad-County

12,650

307

12,117

226

168,693

*Population information taken from the Nevada Health Response Dashboard found at https://nvhealthresponse.nv.gov/

 
Walk-In COVID-19 Clinics
Upcoming COVID-19 vaccination clinics with doses available for walk-ins. Appointments are still available. Visit https://booking.appointy.com/en-US/quadcovidvaccine/bookings/service to schedule an appointment.
  • Friday, May 14, 2021 | 3 p.m. to 4 p.m.
    • Carson City Health and Human Services Main Parking Lot (900 E. Long St, Carson City)
    • Pfizer
  • Tuesday, May 18, 2021 | 9 a.m. to 10 a.m.
    • Fuji Park (701 Old Clear Creek Rd, Carson City)
    • Pfizer
 
Drive-Thru COVID-19 Testing for Quad-County Residents 
Testing is for Quad-County (Carson City, Douglas, Lyon, and Storey County) residents ONLY, all others will be turned away. Testing is free of charge, no appointments or reservations. To view all upcoming events visit https://gethealthycarsoncity.org/events/.

Date

Time

Location

5/13/2021

9 a.m. to 10:30 a.m.

Mills Park Seely Loop

Seely Loop, Carson City (Enter off of Saliman Rd)

5/14/2021

9 a.m. to 10:30 a.m.

Storey County Emergency Management Satellite Office

20 E St, Virginia City

For COVID-19 questions, vaccine appointment assistance, or to arrange for testing, call the Quad-County COVID-19 Hotline Monday through Friday, 8:30 am to 4:30 pm. The phone number is (775) 434-1988.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment